Bastien Joubert Selected Research

Nervous System Paraneoplastic Syndromes

1/2020	Diagnostic yield of commercial immunodots to diagnose paraneoplastic neurologic syndromes.
11/2019	Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bastien Joubert Research Topics

Disease

11	Neoplasms (Cancer) 08/2022 - 10/2015
9	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 09/2022 - 01/2016
9	Encephalitis (Encephalitis, Rasmussen) 05/2022 - 10/2015
9	Autoimmune Diseases of the Nervous System 01/2022 - 10/2015
7	Glioma (Gliomas) 09/2022 - 11/2017
7	Cerebellar Ataxia (Dysmetria) 08/2022 - 04/2016
5	Ataxia (Dyssynergia) 01/2020 - 04/2016
4	Epilepsy (Aura) 09/2022 - 01/2019
4	Seizures (Absence Seizure) 09/2022 - 01/2016
3	Myasthenia Gravis 03/2022 - 03/2017
3	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2018
3	Nervous System Diseases (Neurological Disorders) 07/2021 - 01/2020
3	Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome) 01/2021 - 01/2018
3	Thymoma (Thymic Carcinoma) 10/2020 - 01/2016
3	Isaacs Syndrome (Neuromyotonia) 10/2020 - 01/2016
2	Anterograde Amnesia 01/2022 - 01/2017
2	Disease Progression 01/2022 - 05/2018
2	Temporal Lobe Epilepsy 07/2021 - 07/2020
2	Genetic Predisposition to Disease (Genetic Predisposition) 07/2021 - 07/2020
2	Colorectal Neoplasms (Colorectal Cancer) 10/2020 - 03/2017
2	Nervous System Paraneoplastic Syndromes 01/2020 - 11/2019
1	Atrophy 09/2022
1	Drug Resistant Epilepsy 09/2022
1	Central Nervous System Diseases (CNS Diseases) 03/2022
1	Meningitis 03/2022
1	Lung Neoplasms (Lung Cancer) 03/2022
1	Neurosarcoidosis 01/2022
1	Sarcoidosis (Schaumann Disease) 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Memory Disorders (Memory Loss) 01/2022
1	Leukocytosis (Pleocytosis) 10/2021
1	Inflammation (Inflammations) 08/2021
1	Stiff-Person Syndrome (Stiff Man Syndrome) 07/2021
1	Cranial Nerve Diseases (Cranial Nerve Disorders) 01/2021
1	Paralysis (Palsy) 01/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Confusion (Bewilderment) 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Alveolar Rhabdomyosarcoma 01/2020
1	Parkinsonian Disorders (Parkinsonism) 01/2020
1	Mesothelioma 11/2019
1	Cognitive Dysfunction 05/2018
1	Mental Disorders (Mental Disorder) 05/2018
1	Glioblastoma (Glioblastoma Multiforme) 05/2018
1	Neurodevelopmental Disorders 01/2018
1	Brain Diseases (Brain Disorder) 01/2018
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2018
1	Sarcoma (Soft Tissue Sarcoma) 11/2017
1	Intellectual Disability (Idiocy) 11/2017
1	alpha-Thalassemia 11/2017

Drug/Important Bio-Agent (IBA)

21	AntibodiesIBA 03/2022 - 10/2015
11	AutoantibodiesIBA 05/2022 - 10/2015
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2015
6	Leucine (L-Leucine)FDA Link 09/2022 - 10/2020
5	Immune Checkpoint InhibitorsIBA 08/2022 - 11/2019
5	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 07/2021 - 10/2019
3	AntigensIBA 08/2022 - 01/2019
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
2	Surface Antigens (Surface Antigen)IBA 08/2022 - 03/2017
2	adenylate kinase 5IBA 10/2021 - 01/2017
2	Netrin-1IBA 10/2020 - 03/2017
2	SteroidsIBA 01/2020 - 01/2020
2	IpilimumabIBA 01/2020 - 11/2019
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2020 - 05/2018
2	NivolumabIBA 11/2019 - 01/2018
2	Bevacizumab (Avastin)FDA Link 05/2018 - 11/2017
2	Lomustine (CCNU)FDA Link 05/2018 - 11/2017
2	Temozolomide (Temodar)FDA LinkGeneric 05/2018 - 11/2017
2	Glutens (Glutelin)IBA 01/2018 - 04/2016
1	Pharmaceutical PreparationsIBA 09/2022
1	anti-leucine-rich glioma-inactivated 1 autoantibodyIBA 09/2022
1	LigandsIBA 03/2022
1	Programmed Cell Death 1 ReceptorIBA 03/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	Amyloid beta-PeptidesIBA 01/2022
1	Glial Fibrillary Acidic ProteinIBA 01/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022
1	AD 20 (AD-20)IBA 01/2022
1	Biological ProductsIBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022
1	Azathioprine (Imuran)FDA LinkGeneric 01/2022
1	Oligoclonal BandsIBA 10/2021
1	HLA-DRB1*07 antigenIBA 01/2021
1	metabotropic glutamate receptor 2IBA 01/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020
1	pembrolizumabIBA 11/2019
1	Irinotecan (Camptosar)FDA LinkGeneric 05/2018
1	N-Methylaspartate (NMDA)IBA 05/2018
1	VaccinesIBA 11/2017
1	Vincristine (Oncovin)FDA LinkGeneric 11/2017
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 11/2017

Therapy/Procedure

5	Therapeutics 03/2022 - 01/2016
4	Immunotherapy 08/2022 - 01/2017
2	Drug Therapy (Chemotherapy) 05/2018 - 11/2017
1	Aftercare (After-Treatment) 11/2019
1	Precision Medicine 01/2019
1	Chemoradiotherapy 05/2018
1	Radiotherapy 11/2017